Recognizing hemolysis and its mechanism
15 min
Skills you'll build4 skills
- Recognize hemolysis from haptoglobin, indirect bilirubin, LDH, and reticulocyte results
- Tell immune, fragmentation, and intrinsic hemolysis apart using the DAT and film
- Recognize when a normal G6PD result cannot exclude deficiency
- Recognize a spherocyte in the monolayer of a blood film
At the bench: Relate red cell indices and morphology to the anemia workup
Try first
Get the idea
Use the explanation to check your first decision.
Laboratory markers of hemolysis
No single result proves that red cells are being destroyed faster than the marrow can replace them.1 Hemolysis raises the reticulocyte count once the marrow responds, raises indirect bilirubin and LDH as cells break down, and lowers haptoglobin as it binds the released hemoglobin.1 LDH also rises with liver disease, tissue injury, ineffective erythropoiesis, and a hemolyzed collection, so a raised LDH alone does not establish hemolysis. A low haptoglobin, a raised indirect bilirubin, and a rising reticulocyte count on a properly collected specimen, interpreted together, support red-cell destruction.
Extravascular and intravascular hemolysis
| Pattern | Key findings |
|---|---|
| Extravascular | Reticulocytosis, indirect bilirubin and LDH increase, haptoglobin decrease, spherocytes in some disorders |
| Intravascular | Marked haptoglobin depletion, plasma free hemoglobin, hemoglobinuria, schistocytes in fragmentation disorders |
Identifying the mechanism
The direct antiglobulin test (DAT) and the film help identify the mechanism. Spherocytes form in warm autoimmune hemolysis and in hereditary spherocytosis, so a reactive DAT for IgG or C3d, interpreted with objective hemolysis and the transfusion and drug history, supports an immune cause.2 A nonreactive DAT with a family pattern points toward membrane studies such as eosin-5'-maleimide (EMA) binding.4 Schistocytes point toward fragmentation.
A normal G6PD result during an episode
Reticulocytes have more glucose-6-phosphate dehydrogenase (G6PD) activity than older red cells, and the most deficient cells are lost first during hemolysis, so an assay run during or soon after an episode can be normal in a deficient patient. Recent transfusion can mask deficiency in the same way.3 State the limitation in the report, and repeat the quantitative assay at steady state, commonly 2 to 3 months later.3
Follow the bench demonstration
Sources for this step
References
- Keohane EM, Preston MM, Mirza KM, Walenga JM, eds. Rodak's Hematology: Clinical Principles and Applications. 7th ed. Elsevier; 2025. Accessed September 26, 2026. https://www.us.elsevierhealth.com/rodaks-hematology-9780323936507.html
- Michel M, Crickx E, Fattizzo B, Barcellini W. Autoimmune haemolytic anaemias. Nat Rev Dis Primers. 2024;10(1):82. doi:10.1038/s41572-024-00566-2
- Luzzatto L, Ally M, Notaro R. Glucose-6-phosphate dehydrogenase deficiency. Blood. 2020;136(11):1225-1240. doi:10.1182/blood.2019000944
- Wu Y, Liao L, Lin F. The diagnostic protocol for hereditary spherocytosis: 2021 update. J Clin Lab Anal. 2021;35(12):e24034. doi:10.1002/jcla.24034
Watch one
Read each decision and its explanation.
A hemoglobin of 8.9 g/dL is falling further over 2 days. The reticulocyte count is increased, indirect bilirubin and LDH are increased, and haptoglobin is undetectable. The film shows spherocytes in the monolayer and no schistocytes. The DAT is positive for IgG. The patient has no personal or family history of anemia and no recent transfusion. What mechanism does the pattern support?
- Check the markers together. Reticulocytes, bilirubin, and LDH are increased, and haptoglobin is undetectable, so hemolysis is present.
Hemolysis is confirmed before its type is identified.
- Review the film. Spherocytes are present and no schistocytes are seen, which argues against a fragmentation process.
Red-cell morphology narrows the mechanism before serologic results are reviewed.
- Check the DAT. It is positive for IgG, which supports an immune cause when interpreted with objective hemolysis.
Spherocytes cannot distinguish an immune cause from a hereditary one.
- Check the history. There is no personal or family history of anemia and no recent transfusion, so nothing argues against an acquired immune cause.
A family pattern or long-standing mild anemia would point toward hereditary spherocytosis.
Your turn
Use it
Read the case evidence, then make each decision. The step is complete without it.
- A woman, MRN 0271946, is admitted with fatigue and yellowing of the eyes.
- Her hemoglobin has fallen since admission 2 days ago.
- She has no history of transfusion, recent travel, or new medications.
- The film shows spherocytes in the monolayer and no schistocytes.
- The blood bank reports the DAT positive for IgG.
- A quantitative G6PD assay drawn this admission is within the reference interval.
| Test | Result | Previous | Reference interval | Flag |
|---|---|---|---|---|
| Hemoglobin | 8.9 g/dL LowAdmission: 11.4 g/dL | 11.4 g/dLAdmission | 12.0–15.5 g/dL12.0–15.5 | Low |
| Reticulocytes (absolute) | 185 × 10³/µL HighAdmission: 62 × 10³/µL | 62 × 10³/µLAdmission | 25–100 × 10³/µL25–100 | High |
| Indirect bilirubin | 3.8 mg/dL HighAdmission: 0.6 mg/dL | 0.6 mg/dLAdmission | 0.1–1.0 mg/dL0.1–1.0 | High |
| Lactate dehydrogenase | 410 U/L HighAdmission: 160 U/L | 160 U/LAdmission | 100–220 U/L100–220 | High |
| Haptoglobin | Undetectable LowAdmission: 90 mg/dL | 90 mg/dLAdmission | 30–200 mg/dL30–200 | Low |
Specimen: H 3, L 8, I 2. Serum and EDTA whole blood, drawn on admission day 2
Spherocytes with no schistocytes and a DAT positive for IgG, with no family or transfusion history, point to immune-mediated hemolysis. The G6PD was drawn during the episode, so it cannot be reported as excluding deficiency.
Review missed questions
For reference
Sources checked